LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Method Detects Bacterial Infection in Preterm Infants

By LabMedica International staff writers
Posted on 12 Apr 2016
Print article
Image: The cobas 8000 modular analyzer system (Photo courtesy of Roche Diagnostics).
Image: The cobas 8000 modular analyzer system (Photo courtesy of Roche Diagnostics).
A new criterion has been proposed for diagnosis of bacterial infection in preterm infants and using this method could lead to early diagnosis and treatment for bacterial infection and improve the prognosis for preterm infants.

Infants born prematurely do not have fully developed immune functions and compared to full-term infants, and if preterm infants suffer a bacterial infection there is a higher chance of fatality or negative impact on future growth and development.

Scientists at Kobe University (Japan) examined 1,267 serums from 283 newborns at the neonatal intensive care unit in Kobe University Hospital between June and December 2014. The enrolled newborns were divided into three infant groups as follows: 37 preterm of less than 34 weeks’ gestational age (GA); 61 late preterm of 34 to 36 weeks’ GA, and 185 term infants equal to or greater than 37 weeks’ GA.

Serum procalcitonin (PCT), was used as a marker used for early detection of bacterial infection in adults and children. Serum PCT measurement was performed using 30 μL of serum, the serum PCT concentration was measured by electrochemical luminescence immunoassay using the COBAS 8000e analyzer (Roche Diagnostics, Basel, Switzerland). The results demonstrated that PCT levels in full-term infants rose temporarily one day after birth, returning to the normal level for adults within five days (0.1ng/mL). However, for preterm infants it took nine days after birth for PCT to return to normal levels. Based on these results, the group plotted two reference curves: 50th percentile and 90th percentile values. When they superimposed three cases of preterm infants with bacterial infection on these curves, it clearly showed that in all three cases the serum PCT concentrations were higher than the 95th percentile values.

The authors concluded that that the physiological feature in preterm infants was significantly different from that in late preterm infants, even in those less than 37 weeks’ gestational age. To detect late-onset bacterial infection and sepsis, an age-specific percentile-based reference curve may be useful in preterm infants. Ichiro Morioka, MD, a professor of pediatrics and senior author of the study said, “We could also potentially use this method to limit unnecessary use of antibacterial agents. Our next step is to verify the precision of diagnoses based on these reference curves.” The study was published on April 1, 2016, in the journal Scientific Reports.

Related Links:

Kobe University 
Roche Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more